Biopsy Devices Market Size Projected to Reach USD 5.08 Billion by 2035; Increasing Incidence of Cancer to Drive Market Growth Globally – SNS Insider
Rising Demand for Minimally Invasive, Image-Guided Procedures and Expanding Healthcare Infrastructure Accelerate Global Market Expansion.
Austin, United States, March 20, 2026 (GLOBE NEWSWIRE) — Biopsy Devices Market Size & Growth Analysis:
According to SNS Insider, The Biopsy Devices Market size is valued at USD 2.73 Billion in 2025 and is projected to reach USD 5.08 Billion by 2035, growing at a CAGR of 6.52% during 2026–2035. Strong market growth is anticipated between 2026 and 2035 due to factors such as rising cancer incidence, increased demand for minimally invasive diagnostic procedures, growing acceptance of image-guided techniques, and developing healthcare infrastructure.
Market Size and Forecast:
- Market Size in 2025: USD 2.73 Billion
- Market Size by 2035: USD 5.08 Billion
- CAGR: 6.52% from 2026 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Get a Sample Report of Biopsy Devices Market: https://www.snsinsider.com/sample-request/9829
The U.S. Biopsy Devices Market has been valued at USD 0.95 Billion in 2025 and is expected to reach USD 1.62 Billion in 2035, growing at a CAGR of 5.62% from 2026 to 2035. The high incidence of cancer, a sophisticated healthcare system, and the acceptance of minimally invasive, image-guided biopsy techniques are the market’s main drivers.
Rising Cancer Incidence and Growing Demand for Minimally Invasive Diagnostics Drive Market Growth Globally
For improved outcomes, hospitals, diagnostic facilities, and clinics are increasingly utilizing cutting-edge technologies, such as vacuum-assisted, MRI-guided, and image-guided biopsy procedures. These technologies are expanding due to improvements in safety, image guidance, and precision sampling.
High Device Costs and Limited Reimbursement Policies Drive Market Growth Globally
Access to cutting-edge technologies may be restricted by these financial issues, particularly in low- and middle-income nations. Low patient and physician acceptance is also influenced by the dangers of image-guided treatments, including bleeding, infection, and discomfort. Another obstacle to image-guided processes is the shortage of qualified personnel in emerging economies. Another factor driving competitiveness is the availability of substitute diagnostic techniques, like liquid biopsy.
Major Players Listed in this Report:
- Hologic, Inc.
- Becton, Dickinson and Company (BD)
- Cook Group Incorporated
- Argon Medical Devices
- Boston Scientific Corporation
- Gallini Medical
- TSK Laboratory Europe
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Medtronic plc
- FUJIFILM Holdings Corporation
- INRAD Inc.
- Olympus Corporation
- Merit Medical Systems, Inc.
- IZI Medical Products
- Danaher Corporation
- Devicor Medical Products (Leica Biosystems/Danaher)
- C.R. Bard (BD)
- Stryker Corporation
- Siemens Healthineers
Segmentation Analysis:
By Product Type
Needle Based Biopsy Guns held the largest market share of 43.25% in 2025 as these devices are widely used in the detection of breast, prostate, and lung cancers. Biopsy Guidance System are expected to grow at the fastest CAGR of 7.63% during 2026–2035 due to increased demand for precision medicine, integration with various imaging modalities, such as MRI and ultrasound, and adoption of AI-assisted guidance systems.
By Guidance Technique
Ultrasound-Guided Biopsy dominated with 32.71% market share in 2025 due to its widespread use in breast, thyroid, and soft tissue diagnostics. MRI-Guided Biopsy are projected to record the fastest CAGR of 8.91% through 2026–2035 as growth in this segment is fueled by the demand for precision medicine, an increase in prostate and breast cancer, and technological improvements in MRI-guided biopsy devices.
By Application
Breast Biopsy accounted for the highest market share of 36.45% in 2025 driven by the large prevalence rate of breast cancer worldwide and the popularity of screening programs. Prostate Biopsy are expected to grow at the fastest CAGR of 20.76% during the forecast period due to the increasing rate of prostate cancer and the use of MRI technology.
By End-User
Hospitals & Clinics dominated with a 53.11% share in 2025 due to high patient volume, sophisticated facilities, and widespread adoption of minimally invasive biopsy procedures. Diagnostics & Imaging Centres are anticipated to expand at the fastest CAGR of 7.74% through 2026–2035 owing to the increased demand for outpatient diagnostics, image-guided biopsy procedures, and the trend in the health system towards specialized facilities for diagnosis.
Need Any Customization Research on Biopsy Devices Market, Enquire Now: https://www.snsinsider.com/enquiry/9829
Biopsy Devices Market Segmentation
By Product Type
- Needle Based Biopsy Guns
- Biopsy Guidance System
- Biopsy Needles
- Biopsy Forceps
- Others
By Guidance Technique
- Ultrasound-Guided Biopsy
- MRI-Guided Biopsy
- CT-Guided Biopsy
- Stereotactic-Guided Biopsy
- Others
By Application
- Breast Biopsy
- Prostate Biopsy
- Lung Biopsy
- Others
By End User
- Hospitals & Clinics
- Diagnostic & Imaging Centres
- Academic & Research Institutes
- Others
Regional Insights:
The North America biopsy devices market dominates globally, driven by rising cancer cases, well-established healthcare infrastructure, and high adoption of minimally invasive diagnostic procedures.
The Asia Pacific market for biopsy devices is the fastest-growing market worldwide. The rising incidence of cancer cases, modernization of healthcare infrastructure, and the increased preference for minimally invasive diagnostic procedures are contributing factors to the high growth rate of the Asia Pacific market.
Recent Developments:
- In 2025, Hologic Inc breast biopsy portfolio accounted for a significant share of global procedures, reinforcing its leadership in minimally invasive cancer diagnostics and patient-centric care.
- In 2025, Becton, Dickinson and Company’s (BD) biopsy devices were utilized across thousands of hospitals and clinics, making it a cornerstone provider in minimally invasive diagnostic solutions.
Exclusive Sections of the Report (The USPs):
- ADOPTION & USAGE METRICS – helps you understand utilization trends across needle-based and vacuum-assisted biopsy devices, adoption of image-guided systems, and the shift toward minimally invasive and AI-assisted procedures.
- OPERATIONAL & PERFORMANCE BENCHMARKS – helps you evaluate procedure time, tissue sampling accuracy, device reliability, complication rates, and the efficiency impact of disposable accessories.
- TECHNOLOGY & INNOVATION INSIGHTS – helps you track adoption of integrated imaging systems, growth in MRI-compatible and vacuum-assisted devices, and advancements in automation, miniaturization, and tissue preservation.
- CLINICAL SAFETY & PRECISION METRICS – helps you assess patient safety outcomes, reduction in procedural risks, and improvements in diagnostic accuracy through advanced biopsy technologies.
- END-USE & DEMAND ANALYSIS – helps you identify adoption trends across hospitals, diagnostic centres, and specialty clinics, along with the impact of rising cancer screening programs on device demand.
- REGIONAL & MARKET EXPANSION INSIGHTS – helps you understand geographic demand variations and growth opportunities driven by increasing adoption in emerging healthcare markets and oncology-focused facilities.
Biopsy Devices Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 2.73 Billion |
| Market Size by 2035 | USD 5.08 Billion |
| CAGR | CAGR of 6.52% From 2026 to 2033 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Purchase Single User PDF of Biopsy Devices Market Report (20% Discount): https://www.snsinsider.com/checkout/9829
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Market Overview
4. Statistical Insights & Trends Reporting
5. Biopsy Devices Market Segmental Analysis & Forecast, By Product Type
6. Biopsy Devices Market Segmental Analysis & Forecast, By Guidance Technique
7. Biopsy Devices Market Segmental Analysis & Forecast, By Application
8. Biopsy Devices Market Segmental Analysis & Forecast, By End User
9. Biopsy Devices Market Segmental Analysis & Forecast, By Region
10. Competitive Landscape
11. Analyst Recommendations
12. Assumptions
13. Disclaimer
14. Appendix
Browse Other Reports
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.
